1004 / 1084
c. Baseline and sequential samples from
patients presenting clinically relevant events
may be interrogated
to identify predictive or
pharmacodynamic associated biomarkers
d. Sequential samples of patients presenting
initial responses may be used to identify
biomarkers associated with sustained response
and/ or decreased tumor burden
; or with
development of acquired resistance and/ or
increased tumor burden
03/28/2017